Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma

Diagnostic Molecular Pathology

Volumn 15, Issue 3, 2006, Pages 157-161

  Yang, Xiaohong Rose ^a   Charette, Lori A ^b   Garcia Closas, Montserrat ^a   Lissowska, Jolanta ^c   Paal, Edina ^d   Sidawy, Mary ^d   Hewitt, Stephen M ^a   Rimm, David L ^b   Sherman, Mark E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Breast cancer; DCIS; TDLUs; Tissue microarrays (TMAs)

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST; BREAST CARCINOMA; BREAST DUCT; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; METHODOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; TISSUE MICROARRAY; VALIDATION PROCESS;

BREAST NEOPLASMS; CARCINOMA; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TISSUE ARRAY ANALYSIS;

EID: 33748307653     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pdm.0000213453.45398.e0     Document Type: Article

References (7)

1. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest. 2000;80:1943-1949.
2. Kallioniemi OP, Wagner U, Kononen J, et al. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet. 2001;10:657-662.
3. Henshall S. Tissue microarrays. J Mammary Gland Biol Neoplasia. 2003;8:347-358.
4. Garcia-Closas M, Egan KM, Newcomb PA, et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet. 2006;Feb 17; [E-pub ahead of print].
5. Jirstrom K, Ringberg A, Ferno M, et al. Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence. Br J Cancer. 2003;89:1920-1926.
6. Rosen DG, Huang XL, Deavers MT, et al. Validation of tissue microarray technology in ovarian carcinoma. Modern Pathol. 2004;17:790-797.
7. Zhang DH, Salto-Tellez M, Putti TC, et al. Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer. Modern Pathol. 2003;16:79-84.